- Home
- HCAT
HCAT
Health Catalyst Inc
as 12-20-2024 4:00pm EST
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SOUTH JORDAN |
| Market Cap: | 464.4M | IPO Year: | 2019 |
| Target Price: | $11.75 | AVG Volume (30 days): | 588.2K |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.42 - $11.41 | Next Earning Date: | 11-06-2024 |
| Revenue: | $302,062,000 | Revenue Growth: | 4.15% |
| Revenue Growth (this year): | 6.04% | Revenue Growth (next year): | 11.19% |
Stock Insider Trading Activity of Health Catalyst Inc (HCAT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Llewelyn Linda | HCAT | Chief People Officer | Dec 16 '24 | Sell | $7.88 | 6,442 | $50,793.88 | 98,702 | |
| Landry Benjamin | HCAT | General Counsel | Dec 6 '24 | Sell | $8.32 | 19,268 | $160,294.35 | 72,250 | |
| LeSueur Daniel | HCAT | Chief Operating Officer | Dec 4 '24 | Sell | $7.70 | 22,773 | $175,242.79 | 96,462 | |
| Freeman Kevin Lee | HCAT | Chief Commercial Officer | Dec 1 '24 | Sell | $8.94 | 7,500 | $67,073.25 | 236,950 | |
| Llewelyn Linda | HCAT | Chief People Officer | Nov 15 '24 | Sell | $8.50 | 1,365 | $11,602.50 | 98,702 | |
| LeSueur Daniel | HCAT | Chief Operating Officer | Nov 5 '24 | Sell | $7.70 | 5,209 | $40,127.01 | 96,462 | |
| Llewelyn Linda | HCAT | Chief People Officer | Oct 15 '24 | Sell | $8.16 | 1,324 | $10,803.84 | 98,702 | |
| LeSueur Daniel | HCAT | Chief Operating Officer | Oct 3 '24 | Sell | $7.68 | 5,209 | $40,011.37 | 96,462 |
Latest Health Catalyst Inc News
HCAT Breaking Stock News: Dive into HCAT Ticker-Specific Updates for Smart Investing
GlobeNewswire
12 days ago
Health Catalyst to Participate in Upcoming Investor Conference
StockStory
18 days ago
Earnings To Watch: Domo (DOMO) Reports Q3 Results Tomorrow
StockStory
18 days ago
What To Expect From Samsara’s (IOT) Q3 Earnings
PR Newswire
a month ago
Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare
GlobeNewswire
a month ago
Health Catalyst to Participate in Upcoming Investor Conferences
GlobeNewswire
a month ago
Health Catalyst to Participate in Upcoming Investor Conference
Simply Wall St.
a month ago
One Health Catalyst Insider Raised Their Stake In The Previous Year
Thomson Reuters StreetEvents
a month ago
Q3 2024 Health Catalyst Inc Earnings Call
Compare HCAT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HCAT Health Catalyst Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.